期刊文献+

土壤样品中粘细菌的分离鉴定及其生物活性检测 被引量:5

Isolation,identification and biological activity of myxobacteria from soils
原文传递
导出
摘要 【目的】从土壤样品中分离粘细菌,对其进行纯化、归类与鉴定,以丰富粘细菌菌种资源;对纯化得到的粘细菌进行抑菌、杀虫及抗肿瘤生物活性的分析,为粘细菌次级代谢产物的开发奠定基础。【方法】采用灭活大肠杆菌和滤纸片诱导子实体法从土样中分离粘细菌,结合形态观察、生理生化特征和16S r DNA基因序列同源性分析,对分离到的各菌株进行鉴定并归类。通过平板扩散法、昆虫口服毒性测试、肿瘤细胞毒性实验等方法,检测粘细菌代谢产物生物活性。【结果】共分离得到35株粘细菌,初步分类为:粘球菌属(Myxococcus)9株;珊瑚球菌属(Corallococcus)9株;侏囊菌属(Nannocystis)11株;堆囊菌属(Sorangium)6株。从其中纯化得到8株粘细菌,对其进行了鉴定并命名。发现了具有高效且广谱的肿瘤细胞毒性效应菌株S22,S51和S55也具同样的细胞毒性;另外,还发现具有肿瘤细胞毒性的菌株S20和S22对枯草芽胞杆菌和白色念珠菌也具有较好的抑菌活性。【结论】土壤中存在丰富的粘细菌资源,发现了具有肿瘤细胞毒性的弱小珊瑚球菌与具有抑菌和强抗肿瘤活性的大孢珊瑚球菌,粘细菌是活性天然产物与新药开发的重要资源。 [ Objective] Purpose of this work was to screen myxobacteria from soils and study their biological activities towards pathogenic bacteria, tumor cells and insects. [ Methods] Through inactivated E. coli and filter paper inducing methods, we isolated and purified myxobacteria from soil samples. Then we identified these purified strains based on morphological observation, physiological and biochemical characteristics, and the 16S rDNA sequences homologous analysis. By plate diffusion experiments, oral toxicity tests and tetrazolium assays, we investigated the biological activities of the myxobacterial cuhuresupernatant. [ Results] We isolated 35 myxobacterial strains and classified them as 4 genera: Myxococcus (9) , Corallococcus (9) , Nannocystis ( 11 ) and Sorangium (6). Eight purified myxobacteria were identified and named. Cytotoxicity tests show that strain C. macrospores S22 had potent and broad-spectrum cytotoxic effect on tumor cell lines including B16, 4T1, HeLa and HCT-ll6, so did the strains M. fulvus S51, C. exiguus S22 and M. Xanthus S55. Additionally, C. macrospores S22 also shows inhibitory activity to pathogenic bacteria Bacillus subtillis and Candida albicans. [ Conclusion] Myxobacteria are widely distributed in natural soils. C. macrosporus has potent toxicity against cancer cells and pathogenic bacteria; and C. exiguus with antitumor activity. The myxobacterial strains are promising resources for discovery and development of new active natural products and drugs.
出处 《微生物学报》 CAS CSCD 北大核心 2014年第12期1429-1437,共9页 Acta Microbiologica Sinica
基金 国家"973项目"(2011CB111680) 国家"863计划"(2011AA10A203) 湖南省生物发育工程及新产品研发协同创新中心项目(20134486)~~
关键词 粘细菌 分离鉴定 生物活性 myxobateria, isolation and identification, biological activity assays
  • 相关文献

参考文献27

  • 1Brenner D,Krieg N,Staley J.The proteobacteria(PartC):the alpha-, beta-, delta-, and epsilonproteobacteria.Garrity GM.Bergey ’ s Manual ofSystematic Bacteriology,2005:1059-1144. 被引量:1
  • 2IizukaT, JojimaY, FudouR, Hiraishi A, Ahn JW,Yamanaka S.Plesiocystis pacifica gen.nov.,sp.nov.,amarine myxobacterium that contains dihydrogenatedmenaquinone,isolated from the pacific coasts of Japan.International Journal of Systematic and EvolutionaryMicrobiology,2003,53:189-195. 被引量:1
  • 3Zhang YQ,Li YZ,Wang B,Wu ZH,Zhang CY,GongX,Qiu ZJ,Zhang Y.Characteristics and living patterns ofmarine myxobacterial isolates.Applied and EnvironmentalMicrobiology,2005,6(71):3331-3336. 被引量:1
  • 4Thomas SH,Elizabeth PC,Phillip MJ,Sanford RA,Frank EL.Diversity and distribution of Anaeromyxobacterstrains in a uranium-contaminated subsurface environmentwith a nonuniform groundwater flow.Applied andEnvironmental Microbiology,2009,75 (11):3679-3687. 被引量:1
  • 5Dawid W.Biology and global distribution of myxobacteriain soils.Federation of European Microbiological SocietiesMicrobiology Reviews,2000,24(4):403-427. 被引量:1
  • 6Shimkets LJ, Reichenbach H, Dworkin M.Themyxobacteria.The Prokaryotes,2006,7:31-115. 被引量:1
  • 7Herrmann J,Elnakady Ya,Wiedmann Rm,Ullrich A,Rohde M, Kazmaier U, Vollmar Am, Müller R.Pretubulysin:from hypothetical biosynthetic intermediateto potential lead in tumor therapy.PLoS One,2012,7(5):e37416. 被引量:1
  • 8Chai Y,Pistorius D,Ullrich A,Weissman KJ,KazmaierU,Müller R.Discovery of 23 natural tubulysins fromAngiococcus disciformis An d48 and Cystobacter SBCb004.Chemistry & Biology,2010,17:296-309. 被引量:1
  • 9Horstmann N,Essig S,Bockelmann S,Wieczorek H,Huss M,Sasse F,Menche D.Archazolid A-15-O-β-Dglucopyranosideand iso-archazolid B:potent V-ATPaseinhibitory polyketides from the myxobacteria Cystobacterviolaceus and Archangium gephyra.Journal of NaturalProducts,2011,74,1100-1105. 被引量:1
  • 10Garcia R,Krug D,MüllerR.Discovering natural productsfrom myxobacteria with emphasis on rare producer strainsin combination with improved analytical methods.Methodsin Enzymology,2009,458:59-91. 被引量:1

二级参考文献85

  • 1王赫,张庆林.粘细菌代谢产物的研究进展[J].国外医学(药学分册),2005,32(4):246-250. 被引量:7
  • 2王远亮,张彩琴.黏细菌产生多样性天然活性物质的研究进展[J].华西药学杂志,2006,21(1):69-71. 被引量:4
  • 3施晓琼,许强芝,刘小宇,韩文菊,刘新利,焦炳华,李越中.六种粘细菌095B06次生代谢产物的分离、鉴定及初步生物学活性研究[J].第二军医大学学报,2007,28(3):266-271. 被引量:6
  • 4F.Gaspari,Y.Paitan,M.Mainini,D.Losi,E.Z.Ron2 and F.Marinelli.Myxobacteria isolated in Israel aspotential source of new anti-infectives[J].Journal ofApplied Microbiology 2005,98,429-439. 被引量:1
  • 5LAWRENCE J.SHIMKETS,MARTIN DWORKIN ANDHANS REICHENBACH.The Myxobacteria[J].Pro-karyotes(2006)7:31-115.DOI:10.1007/0-387-30747-8_3. 被引量:1
  • 6LiPing Zhang,HaiYing Wang.Improved methods of isola-tion and purification of myxobacteria and development offruiting body formation of two strains[J].Journal of Micro-biological Methods 54(2003)21-27. 被引量:1
  • 7Till F.Schμberle,Emilie Goralski,Edith Neu.MarineMyxobacteria as a Source of Antibiotics-Comparison ofPhysiology,Polyketide-Type Genes and Antibiotic Pro-duc of Three New Isolates of Enhygromyxa salination[J].Mar.Drugs 2010,8,2466-2479. 被引量:1
  • 8George M.Garrity;Julia A.Bell;Timothy G.Liburn.Bergey's manual of systematic bacteriology(second edi-tion,2004).. 被引量:1
  • 9Reichenbach H, Gerth K, Irschik H,et al. Myxobacteria: A sourceof new antibiotios[ J]. Trends Biotechnol, 1988 ,6 : 115-121. 被引量:1
  • 10Reichenbach H,Hofle G. Biologically active secondary metabolitesfrom Myxobacteria[ J]. Biotech Adv, 1993 ,11 :219-277. 被引量:1

共引文献20

同被引文献49

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部